Cancer Clinical Trials Centre, Austin Health, Level 4

Heidelberg, Victoria 3084

0 studies enrolling now · 1 studies all time

What they study most

Diffuse Large B-Cell Lymphoma

Studies at this site

• Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) — Stopped early